Tooth gap: Single crown replacement required in the posterior region
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: General Inclusion criteria: - Age of study participants: 18-80 years at inclusion - Signed informed consent - Patient in good medical and psychological health with availability for follow-up. - Adequate oral hygiene And the following local Inclusion Criteria: - Patient with single-tooth implant indication: missing a single mandibular or maxillary tooth. And in need of implant-supported, single restoration. - Sufficient bone and keratinized soft tissue availability for implant placement without regenerative therapy: Presence of adequate of vertical and horizontal native bone in the recipient sites to allow implant placement without the need for bone regeneration techniques: healed sites with vertically and horizontally at least 1 mm of bone around the implant and thus no need for augmentation; minimum bone height: = 7 mm and minimum bone width: = 5.0 mm. It is also required to present sufficient keratinized gingival tissue (at least 2 mm) and to meet appropriate standards of oral hygiene (plaque and gingival indices <15%), since the study aims to evaluate healthy peri-implant mucosa, and no signs of peri-implant tissue disease are therefore allowable. - Presence of both adjacent teeth. - antagonistic jaw with antagonistic natural dentition or tooth/implant borne rehabilitation which can be used to create a stable occlusal fit with the new restoration.
Exclusion criteria
Exclusion criteria: Exclusion criteria: Any of the following is regarded as a criterion for exclusion from the study: 1. Unlikely to be able to comply with study procedures according to Investigators judgement. 2. Heavy smoking >10 cigarettes per day 3. Present alcohol or drug abuse 4. History of radiation therapy in head and neck region for Tumor therapy 5. History of chemotherapy within 5 years prior to surgery 6. Condition that would compromise post-operative tissue healing or osseointegration 7. High biphosphonate titer: Bisphosphonates or any other medication that would compromise post-operative healing or osseointegration. 8. Known pregnancy at time of inclusion 9. Current or former participation in a clinical study that may interfere with the present study 10. Involvement in the planning and conduct of the study 11. History of bone augmentation in the maxilla within 6 months prior to surgery 12. Uncontrolled pathologic processes in the oral cavity
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Recorded clinical and technical workflow times - Patient-Reported Outcome Measures (PROMs) - Patient-Reported Experience Measures (PREMs) - WES: Esthetic Score - FIPS: Functional Implant Prosthodontic Score - PES: Pink Esthetic Score: | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint: - Crestal bone behavior - Incidence of mucositis | — |
Countries
Germany
Contacts
Goethe-Universität Frankfurt Zentrum der Zahn-, Mund- und Kieferheilkunde Abteilung für Postgraduale Ausbildung